AST5902 mesylate is the primary in vivo metabolite of the tyrosine kinase inhibitor Alflutinib and exhibits antineoplastic activity. It is utilized in oncology research to study EGFR mutation-targeted therapies, with applications in both in vitro cellular assays and in vivo pharmacokinetic and efficacy models.
Molekulargewicht:
650.67
Reinheit:
99.46% (May vary between batches)
CAS Nummer:
[2412155-75-8]
Formel:
C28H33F3N8O5S
Target-Kategorie:
Drug Metabolite,EGFR
Anwendungsbeschreibung:
Solubility: DMSO:55 mg/mL (84.53 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten